| Nature Biotechnology | |
|---|---|
 |
|
| Abbreviated title(s) | Nat Biotechnol |
| Discipline | Biotechnology |
| Language | English |
| Publication details | |
| Publisher | Nature Publishing Group (UK) |
| Publication history | 1996 to present |
| Indexing | |
| ISSN | 1087-0156 |
| Links | |
Nature Biotechnology (Nat Biotechnol; ISSN 1087-0156) is an academic journal covering the science and business of biotechnology.
Nature Biotechnology is a continuation of Bio/Technology (Biotechnology (NY); ISSN 0733-222X), which was founded in 1983 and renamed in 1996. It is published monthly by the Nature Publishing Group, a division of Macmillan Publishers Ltd. Like other Nature journals, there is no external Editorial Board; editorial decisions are made by an in-house team, although peer review by external expert referees forms a part of the review process.
Its 2005 impact factor was 22.7, making it the highest cited research journal in the category of biotechnology and applied microbiology, and one of the 20 most highly cited scientific journals. In comparison, the impact factors of general science journals Science and Nature for the same period were 30.927 and 29.273, respectively.
The current editor of Nature Biotechnology is Andrew Marshall. The founding editor of Bio/Technology was Christopher Edwards, who served from 1983 through early 1994. Douglas McCormick edited Bio/Technology from mid 1984 through late 1993. Susan Hassler then became editor, followed by Dr. Marshall.
   | Nature Biotechnology website - Home : Nature Biotechnology |
|
|
Wikis
Quiz
Search
